Samsung Targets U.S. Drug Market With Remicade Knockoff

Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news